Tina Susan Nova insider trades

Open-market stock purchases and sales by Tina Susan Nova, Director at Aurinia Pharmaceuticals Inc, from SEC Form 4 filings since Dec 31, 2009.

Recent trades

DateStockTradeValue
Jun 4, 2026AUPH Aurinia Pharmaceuticals IncBought (not open market)—
Feb 6, 2026AZTA Azenta, IncBought (not open market)$158K

Companies traded

  • AUPH Aurinia Pharmaceuticals Inc: other filings, last Jun 4, 2026
  • AZTA Azenta, Inc: other filings, last Feb 6, 2026
  • XGN Exagen Inc: other filings, last Jun 10, 2025
  • ARNA Arena Pharmaceuticals Inc: 3 sales, last Mar 11, 2022
  • VCYT Veracyte, Inc: other filings, last Mar 3, 2022
  • OPGN Opgen Inc: other filings, last Sep 2, 2019
  • OPGN,OPGNW Opgen Inc: other filings, last May 4, 2017
  • NSTG NanoString Technologies Inc: other filings, last Apr 29, 2014
  • ADMP Adamis Pharmaceuticals Corp: other filings, last Oct 16, 2013
  • GXDX Genoptix Inc: 6 sales, last Mar 7, 2011
  • CYPB Cypress Bioscience Inc: other filings, last Jan 4, 2010

Get free alerts when Tina Susan Nova files a new trade →